A B S T R A C T 13 C Magnetic Resonance Spectroscopy (MRS) using hyperpolarized 13 C-labeled pyruvate as a substrate offers a measure of pyruvate-lactate interconversion and is thereby a marker of the elevated aerobic glycolysis (Warburg effect) generally exhibited by cancer cells. Here, we aim to compare hyperpolarized [1-13 C]pyruvate MRS with simultaneous 18 F-2-fluoro-2-deoxy-D-glucose (FDG) PET in a cross-sectional study of canine cancer patients. Methods: Canine cancer patients underwent integrated PET/MRI using a clinical whole-body system. Hyperpolarized [1-13 C]pyruvate was obtained using dissolution-DNP. 18 F-FDG PET, dynamic 13 C MRS, 13 C MRS Imaging (MRSI) and anatomical 1 H MRI was acquired from 17 patients. Apparent pyruvate-to-lactate rate constants were estimated from dynamic 13 C MRS. 18 F-FDG Standard Uptake Values and maximum [1-13 C]lactate-to-total-13 C ratios were obtained from tumor regions of interest. Following inspection of data, patients were grouped according to main cancer type and linear regression between measures of lactate generation and 18 F-FDG uptake were tested within groups. Between groups, the same measures were tested for group differences. Results: The main cancer types of the 17 patients were sarcoma (n = 11), carcinoma (n = 5) and mastocytoma (n = 1). Significant correlations between pyruvate-to-lactate rate constants and 18 F-FDG uptake were found for sarcoma patients, whereas no significant correlations appeared for carcinoma patients. The sarcoma patients showed a non-significant trend towards lower 18 F-FDG uptake and higher lactate generation than carcinoma patients. However, the ratio of lactate generation to 18 F-FDG uptake was found to be significantly higher in sarcoma as compared to carcinoma. The results were found both when lactate generation was estimated as an apparent pyruvate-to-lactate rate constant from dynamic 13 C MRS and as an [1-13 C]lactate to total 13 C ratio from 13 C MRSI.
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Conclusions: A comparison of hyperpolarized [1-13 C] pyruvate MRS with simultaneous 18 F-FDG PET indicate that lactate generation and 18 F-FDG uptake in cancers can be related and that their relation depend on cancer type. This finding could be important for the interpretation and eventual clinical implementation of hyperpolarized 13 C. In addition, the differences between the two modalities may allow for better metabolic phenotyping performing hybrid imaging in the form of hyperPET.
Introduction
Clinical imaging of cancer has during the last decades witnessed morphological imaging modalities such as CT and MRI being supplemented and augmented by molecular imaging of tumor function [1] [2] [3] . PET offers whole-body functional imaging and 18 F-2-fluoro-2-deoxy-Dglucose ( 18 F-FDG) PET often in combination with diagnostic CT, is a widely used clinical tool for detection of cancer, staging and assessment of response to therapy [4] [5] [6] . FDG is a glucose analog, which is transported into cells and trapped as FDG-6-phosphate. The 18 F FDG uptake is a measure of regional glucose uptake and thereby an indirect marker of the elevated aerobic glycolysis, Warburg effect, generally exhibited by cancer cells [7, 8] .
Magnetic Resonance Spectroscopy (MRS) can also characterize cancer metabolism [9] and enabled by the development of dissolution Dynamic Nuclear Polarization (d-DNP) [10, 11] , hyperpolarized 13 C MRS has reached clinical accessibility. In particular, 13 C MRS Imaging (MRSI) of prostate cancer using hyperpolarized 13 C-labeled pyruvate as a substrate has been demonstrated in patients [12] . Here, the elevated aerobic glycolysis can be measured through the appearance of the 13 Clactate signal, and dynamic 13 C MRS can provide an estimate of the apparent pyruvate-to-lactate rate constant. The measured rate constant is apparent since it is also affected by e.g. expression of monocarboxylic transporters in the cell membranes.
Accordingly, both 18 F FDG PET and hyperpolarized 13 C-pyruvate MRS are molecular imaging modalities sensitive to glycolysis. However, PET is well-established clinically while hyperpolarized MRS is still at its infancy [11, [13] [14] [15] . The relation between 18 F FDG PET and hyperpolarized 13 C-pyruvate MRS in cancer has been explored in a limited number of preclinical studies using a sequential setup [13, [16] [17] [18] , focusing on feasibility [17] and treatment effects [13, 16, 18] . With the availability of integrated PET and MRI in a clinical, whole-body system [19] , simultaneous PET and hyperpolarized 13 C MRS (hyperPET) [20, 21] is possible. We have recently demonstrated, in a series of 10 canine cancer patients, an overall spatial concordance of 13 C-lactate and 18 F FDG uptake patterns [22] , but have also observed canine cancer patients with a spatial mismatch [23] . Cancer cells utilize both glycolysis and oxidative phosphorylation for energy metabolism [8, 24, 25] and the degree of glycolysis might be heterogeneous across cancer cell types [24, 26] .
To further compare the two modalities of 18 F FDG PET and hyperpolarized 13 C-pyruvate MRS, we investigate in this study the relation between 18 F FDG uptake and apparent pyruvate-to-lactate rate constants in a larger series of canine cancer patients with different cancer types. This allows us to compare 18 F FDG PET and hyperpolarized 13 C-pyruvate MRS estimates of glycolysis in a cross-sectional study, with the very basic hypothesis that tumor 18 F FDG uptake and apparent pyruvate-to-lactate rate constants are correlated and may depend on cancer type.
Materials and methods

Study population
Seventeen canine cancer patients with solid tumors were consecutively enrolled in the study. All patients underwent physical examination as well as routine pre-anesthetic and diagnostic work up laboratory evaluation. Inclusion criteria were diagnosis of malignant tumor type and complete hyperPET data ( 18 F-FDG PET, dynamic 13 C MRS and 13 C MRSI). Exclusion criteria were clinical or laboratory work up precluding anesthesia. All canine cancer patients underwent PET/ MRI with 18 F FDG PET as part of their diagnostic and staging work-up prior to therapy recommendation. Hyperpolarized 13 C MRSI was performed concomitantly. The owners gave informed consent and the study was approved by the Ethics and Administrative Committee, Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen.
Experimental setup
PET/MRI was performed using an integrated system (Siemens Biograph mMR) with a 3 T MR imager. 13 C MRSI utilized a 1 H/ 13 C dualtuned transmit/receive surface flex coil centered on the lesion, or (patient 16, Table 1 ), a 13 C transmit/receive birdcage head coil (RAPID Biomedical).
The canine patients were anesthetized using a bolus injection of Propofol and maintained by administration of air/oxygen enriched gas mixture with Sevoflurane. Heart rate, oxygenation, and blood pressure were monitored throughout the scanning procedure.
Hyperpolarized [1-13 C]pyruvate was obtained using dissolution-DNP (SpinLab, GE Healthcare) using the procedure as described by Gutte et al. [22] . The amount injected was 0.68 mL/kg body weight of 250 mM [1-13 C]pyruvate.
1 H-MRI
Anatomical 1 H MRI included T2 turbo spin echo (tse) [repetition time (TR) 4000 ms, echo time (TE) 89 ms, pixel size 0.6 × 0.5 mm 2 , 19 slices of 3 mm thickness] in 3 planes. A single slice T2-tse angulated and centered as the 13 C MRSI was obtained as a geometrical reference. In most patients, the exam included transverse fat saturated T1-tse [TR 550 ms, TE 6.5 ms, pixel size 0.7 × 0.6 mm 2 , 27 slices of 3 mm thickness] following gadolinium injection (0.1 mL/kg Gadovist). † : Initial diagnosis based on MRI findings prior to referral indicated neoplasia of the right trigeminal/mandibular nervemost likely peripheral nerve sheath tumor (sarcoma). FDG-PET is consistent with neoplasia.
18 F-FDG PET
PET was performed as a single-bed, 5 min acquisition, 30 min or 60 min post injection (p.i.) of 8 MBq/kg 18 F FDG.
Image reconstruction used 3D OP-OSEM with 4 iterations, 21 subsets, matrix 344 × 344, 4 mm 3D Gaussian post-filter and voxel size 2.1 × 2.1 × 2.0 mm 3 . Attenuation correction (AC) utilized vendor supplied algorithm, however in some cases a faulty segmentation of the AC map was observed due to sensitivity profile of the MR surface coil, in which case a semi-automatic delineation of body contours to correct the AC map was performed based on the non-AC PET. 18 F FDG uptake was reported as standardized uptake values (SUV).
13 C-MRS
Calibration of the 13 C MR flip angle was performed using an urea phantom [21] .
Dynamic 13 13 C MRSI, the metabolite ratio of lactate to all modeled peak heights (total Carbon) was calculated for all voxels which had both a lactate and a pyruvate peak height larger than 5 times the standard deviation of the noise in a background region of the spectrum. Ratio images were converted to DICOM for later ROI analysis.
ROI definition
Two sets of tumor PET ROIs were defined corresponding to the dynamic 13 C MRS acquisition and single time point 13 C MRSI, respectively.
The ROI corresponding to dynamic 13 C MRS was delineated based on a 50% of SUV max iso-contour in Mirada XD (version 1.2.0.59, Mirada Medical) and limited to the 13 C MRS volume in case the volume did not cover the entire tumor. FDG uptake of non-neoplastic origin corresponding to e.g. muscle, joints, or nasal mucous membrane was removed. SUV mean , SUV max and ROI volume were recorded.
For the single time point 13 C MRSI, PET was resampled to the 2D imaging plane of the 13 C MRSI in OsiriX (version 4.1.2, PIXMEO) and the tumor was delineated as above. SUV_2D max and the maximum lactate ratio LactateRatio max were recorded.
Comparison of 18 F FDG PET and hyperpolarized 13 C MRS
To explore the relation of FDG uptake and pyruvate-to-lactate interconversion, linear regression was tested for SUV mean , SUV max and 3D ROI volume versus k PL , as well as SUV_2D max versus LactateRatio max . Further, the ratios k PL /SUV mean,max and LactateRatio max /SUV_2D max were calculated for each lesion. Patients were grouped according to main cancer type following inspection of data. Group differences were assessed using a 2-sample unpaired t-test. A p-value of 0.05 was considered significant.
Results
Patients
Seventeen canine cancer patients were included. Six patients had PET acquired nominally 30 min p.i. (all sarcoma), and 11 patients 60 min p.i. (patient 3 had PET delayed to 48 min p.i and was included in the 60 min p.i. group). Cancer types included seven soft tissue (ST) sarcomas, four thyroid carcinomas, two osteosarcomas, one chondrosarcoma, one unspecified sarcoma, one mastocytoma and one squamous cell (SC) carcinoma. Tumor classification was based on histopathology except for patient 10 and 16, which were diagnosed by cytology and combined clinical and imaging findings, respectively ( Table 1) . 
Patient examples
Comparison of apparent lactate generation and 18 F FDG uptake
The apparent pyruvate-to-lactate rate constant k PL obtained from all canine patients varied by a factor of more than 10. Fig. 3a )-c) shows SUV mean , SUV max and Volume from the 3D ROI as function of k PL . Cancer type is denoted in the legend of Fig. 3a ). There is clearly no correlation between apparent pyruvate-to-lactate rate constants and 18 F FDG uptake across patients with all cancer types, Fig. 3a )-b). Upon closer inspection, two main qualitative features can be seen immediately: 1) The sarcoma patients tend to show a linear relation between SUV and k PL across patients, both for PET data obtained 30 min p.i. (filled grey symbols) and 60 min p.i. (filled black symbols). The trend is observed across sarcoma cancer subtypes. No linear trend appears for carcinoma patients. 2) In the group of patients with sarcoma, patients appear to have a combination of lower SUV and higher k PL than the carcinoma (open triangles and square). Of further note, the mastocytoma (open diamond) appears to group with the sarcoma patients.
The tumor volume appears unrelated to k PL . The qualitative trends 1)-2) are replicated by the 2D measurements of maximum lactate ratio and SUV_2D max in the 13 C MRSI imaging plane shown in Fig. 4 .
Results of testing for linear trends between 18 F FDG uptake and lactate generation across patients are shown in Table 2 confirming the qualitative impressions above. Significant slopes appear for k PL versus SUV max (sarcomas 30 and 60 min p.i.), k PL versus SUV mean (sarcomas 60 min p.i.) and LactateRatio max versus SUV_2D max (sarcomas 60 min p.i.). Also, k PL versus SUV mean (sarcomas 30 min p.i.) is close to significance (p = 0.064). No linear relation involving the group of carcinomas is significant; neither is the relation of k PL and tumor volume. No offsets are significant for any of the linear trends tested. Regression lines for significant correlations are included in Figs. 3 and 4 .
The qualitative impression that sarcoma patients showed a combination of higher apparent lactate generation and lower 18 F FDG uptake than sarcoma patients was tested by comparing ratios of apparent pyruvate-to-lactate rate constant k PL to SUV mean and SUV max and likewise the ratio of LactateRatio max to SUV_2D max in patients with 18 F FDG PET obtained 60 min p.i. Results are shown in Table 3 Fig. 5 . The ratios k PL /SUV mean and k PL /SUV max were significantly higher (on average by a factor of approximately 3, p = 0.001 and 0.003) in the group of sarcoma patients as compared to the carcinoma patients. The tendencies to higher k PL and a lower SUV mean,max in sarcoma as compared to carcinoma were not statistically significant. Also, the ratio LactateRatio max /SUV_2D max was significantly higher (on average by a factor of approximately 3, p = 0.001) in the group of sarcoma patients as compared to the carcinoma patients ( Fig. 5) .
Pyruvate TTP was 24.9 ± 6.6 s. TTP, TTI and TTP-TTI were not significantly different between groups of sarcoma and carcinoma patients. Table 1) . 18 F FDG PET in a) sagittal and b) coronal orientation with 3D ROI (outlined in orange color) and c) fused with T2-tse MRI. d) Pyruvate (blue) and lactate (red, multiplied by 10) peak areas. e) 18 F FDG PET in the transverse/oblique orientation of the 13 C MRSI plane with 2D ROI (outlined in green color) and f) fused with T2-tse MRI. g) Lactate ratio from 13 C MRSI fused with T2-tse MRI and h) T2-tse MRI. Table 1) . 18 F FDG PET in a) coronal orientation with 3D ROI (outlined in orange) and b) fused with T2-tse MRI. c) Pyruvate (blue) and lactate (red, multiplied by 10) peak areas as function of time from injection of hyperpolarized pyruvate. d) 18 F FDG PET in the transverse orientation of the 13 C MRSI plane with 2D ROI (outlined in green) and e) fused with T2-tse MRI. f) Lactate ratio from 13 C MRSI fused with T2-tse MRI and g) T2-tse MRI.
Discussion
The study compared measurements of elevated aerobic glycolysis by means of 18 F FDG PET and hyperpolarized [1-13 C]pyruvate MRS in a series of canine patients with solid tumors of different tissue types. The combination of pyruvate-to-lactate rate constants and 18 F FDG uptake appeared to group patients according to main cancer types. Thus, the ratio of apparent pyruvate-to-lactate rate constant to 18 F FDG uptake was found to be significantly higher in sarcoma as compared to carcinoma. Pyruvate-to-lactate rate constants and 18 F FDG uptake correlated well across patients in the sarcoma patient group, but not in the carcinoma patient group. Those results indicate that while lactate generation and 18 F FDG uptake in cancers can be related, their relation depends on cancer tissue type. This finding could be important for the interpretation and eventual clinical implementation of hyperpolarized Fig. 3 . Correlation of FDG uptake and lactate generation. Figure shows tumor 18 F FDG uptake quantified as SUVmean (subfigure a), SUVmax (subfigure b) and ROI Volume (subfigure c) versus apparent pyruvate-to-lactate transfer coefficient k PL . Cancer types are explained in the legend (subfigure a). Lines show linear trends for significant correlations within main cancer types (sarcoma and carcinoma) (see Table 2 ). Fig. 4 . Correlation of FDG uptake and lactate generation, 2D ROI. Figure shows tumor SUV_2Dmax in the 2D plane of the 13 C MRSI versus maximum tumor lactate to pyruvate ratio, LactateRatio max . Grouping of patients and symbols used are the same as in Fig. 3 , and are explained in the legend. The line shows the linear trend for a significant correlation in the group of sarcoma patients ( Table 2) . Correlation of k PL and SUV max p = 0.008 * R 2 = 0.85 p = 0.016 * R 2 = 0.89 p = 0.37 R 2 = 0.21 Correlation of k PL and SUV mean p = 0.064 R 2 = 0.62 p = 0.011 * R 2 = 0.92 p = 0.46 R 2 = 0.14 Correlation of k PL and Volume p = 0.22 R 2 = 0.35 p = 0.13 R 2 = 0.77 p = 0.19 R 2 = 0.38 Correlation of (Lac/ Pyr) max and SUV max p = 0.23 R 2 = 0.27 p = 0.033 * R 2 = 0.83 p = 0.34 R 2 = 0.30
Uncorrected R2 values for linear regression are reported. * P < 0.05. Only a few earlier studies have compared 18 F FDG PET and hyperpolarized [1-13 C]pyruvate MRS in animal models [16, 17] , and using sequential exams as opposed to simultaneous exams performed by us in the combined PET/MR clinical system. In a study of murine lymphoma treatment [16] , a comparable decrease in 18 F FDG uptake and pyruvateto-lactate exchange was found 24 h after chemotherapy, with the decrease in 18 F FDG uptake appearing earliest. A recent treatment study using an ovarian cancer mouse model showed increased pyruvate-tolactate conversion after chemotherapy without a change in 18 F FDG uptake [18] . There was no attempt to correlate 18 F FDG uptake and 13 C MRS across animals in the abovementioned studies. In a study of hepatocellular carcinoma tumor-bearing rats [17] , tumors exhibited increased 18 F FDG uptake and locally increased pyruvate-to-lactate exchange. However, no correlation between PET and MRS data was observed across animals, possibly corresponding to the lack of correlation we observe for the canine carcinoma patients. Previous studies on canine cancer patients from our group [20, 22, 23] focused on single cases, feasibility and spatial concordance of 18 F FDG PET and hyperpolarized [1-13 C]pyruvate MRSI and did not compare data across patients or cancer tissue types.
The apparent pyruvate-to-lactate rate constant reported here was based on dynamic measurements performed in a 40 mm thick slab encompassing the tumor but also surrounding tissues which may influence rate constant estimates. This methodology is common in the field of hyperpolarized 13 C MRS. The overall pattern in the relation between 18 F FDG uptake and lactate generation (linear relation between measures for sarcoma but not carcinoma, higher ratio of lactate generation to 18 F FDG uptake in sarcoma as compared to carcinoma, Fig. 3a, b) was reproduced by measurements based on single time point 13 C MRS imaging (Fig. 4) . This supports the robustness of the findings. The tumors of the present study showed a large heterogeneity of anatomic location which could influence delivery of the hyperpolarized pyruvate substrate; however the delivery times were not different between tumor types. Lactate can also be detected by 1 H MRS [9] but hyperpolarized 13 C MRS provides information on the dynamics of lactate generation, which may be advantageous in the assessment of alterations of tumor cell energy metabolism [33] . Dynamic acquisition of FDG-PET with arterial blood sampling, which would have enabled kinetic modelling of FDG uptake, was not feasible with the present patient setup. Overall, significant correlations of pyruvate-to-lactate rate constants and 18 F FDG uptake appear irrespective of FDG uptake time ( Fig. 3 and Table 2 ), suggesting that kinetic modelling would not alter the conclusions of the study.
We may speculate on why the ratio of lactate generation and 18 F FDG uptake was different for sarcoma and carcinoma in context of the origin of the Warburg effect. The aerobic glycolysis generally exhibited by cancer cells can occur while the cells still use glucose to produce ATP in the mitochondria [8, 24, 25, 29] . Accordingly, the relative contribution of aerobic glycolysis and oxidative phosphorylation may vary [24, 26] . Therefore, the different relation between 18 F FDG uptake and lactate generation in different cancer tissue types may be interpreted as a metabolic signature of the relative contribution from the Warburg effect. If this interpretation can be confirmed by independent experiments including ex vivo validation, the relation between 18 F FDG uptake and lactate generation may be used to shed further light on the origins of the Warburg effect [30, 31] .
From a clinical perspective, the question naturally arises whether 18 F FDG PET and [1-13 C]pyruvate MRSI provides similar or complementary information. Based on the present study we can hypothesize that the combination of 18 F FDG PET and hyperpolarized [1-13 C]pyruvate MRSI (hyperPET), but not the modalities alone, can characterize regulation of glycolysis. Reprogramming of energy metabolism has been proposed as a Hallmark of Cancer [32] and thus hyperPET may provide a new method of better metabolic cancer phenotyping. However, a possible clinical role of such improved phenotyping by hy-perPET will need to be investigated in future human studies.
HyperPET data from six of the canine cancer patients included here was already reported by our group in [20, 22] . However, due to the small number of animals the cross-sectional comparison of 18 F FDG PET and 13 C MRS as presented here was not attempted.
The present study population showed a large heterogeneity of cancer types, lactate generation rate and 18 F FDG uptake. Such heterogeneity is also a common feature of clinical cancer patients and was likely beneficial to explore main differential characteristics of 18 F FDG PET and hyperpolarized 13 C MRS. However, the heterogeneity together with low to intermediate grades hampered a comparison between cancer grade and imaging findings. The correlation of FDG uptake and apparent pyruvate-to-lactate rate constants was evaluated grouping patients according to main cancer tissue types (carcinoma, sarcoma). While soft tissue sarcoma and bone sarcoma appeared to follow a common trend line, this very rough classification may be the reason why no correlation was observed for the group of carcinoma patients.
Clearly, with the small number of animals and the limited number of cancer tissue types, the present data should be viewed as hypothesis generating only. Overall, combined PET/MRI using 13 C hyperpolarized probes seem valuable to improve metabolic phenotyping in cancer.
Conclusion
Comparing 18 F FDG PET and 13 C MRS apparent pyruvate-to-lactate rate constants we found correlation within certain tumor tissue types but not across tumor types. As 13 C MRS apparent pyruvate-to-lactate transfer most likely is the best reflection of aerobic glycolysis (Warburg Fig. 5 . Group differences of FDG uptake and lactate generation. Differences of SUVmean (subfigure a), apparent pyruvate-to-lactate transfer coefficient k PL (subfigure b) and k PL /SUVmean (subfigure c) between groups of carcinoma and sarcoma patients are illustrated. Only k PL /SUVmean shows a significant group difference (p-values are reported in Table 3 ). All PET data are obtained nominally 60 min p.i. Symbols are the same as in Figs. 3 and 4 . effect) this demonstrates that 18 F FDG PET cannot in general be regarded as a clear indicator of the Warburg effect, but within certain tumor tissue types and microenvironment conditions there may be a strong correlation. The differences between the two modalities may allow for better metabolic phenotyping performing hybrid imaging in the form of hyperPET.
